AVROBIO Inc (AVRO)

(10% Negative) AVROBIO, INC. (AVRO) Announces Delay in deficient Trials for Cystinosis Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment